Fig. 2From: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cellsLS and TS calculated for the treatment with doxorubicine serial passages (P0: control cells, P12 and P24 a Hs578T cells and b MDA-MB-231 cellsBack to article page